Successful Treatment of Chylothorax and Chylopericardium by Radiotherapy in Lung Cancer
-
- Shintani Ryota
- Department of Respiratory Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan
-
- Sekine Akimasa
- Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan
-
- Murohashi Kota
- Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan
-
- Otoshi Ryota
- Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan
-
- Kasuya Takeo
- Department of Radiology, Kanagawa Cardiovascular and Respiratory Center, Japan
-
- Oda Tsuneyuki
- Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan
-
- Baba Tomohisa
- Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan
-
- Komatsu Shigeru
- Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan
-
- Ogura Takashi
- Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan
-
- Inoue Yoshikazu
- Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Japan
この論文をさがす
抄録
<p>A 58-year-old man was diagnosed with stage IVB lung adenocarcinoma in the right upper lobe and underwent systemic chemotherapy. Seven months after the diagnosis, large left pleural and pericardial effusion was detected. The patient developed both chylothorax and chylopericardium following superior vena cava (SVC) obstruction with mediastinal lymphadenopathy caused by lung carcinoma. Since conservative treatment of the chyle leakage was ineffective, we administered radiotherapy to treat the SVC obstruction and mediastinal lymphadenopathy. After radiotherapy, the chylothorax and chylopericardium gradually resolved, and no further chyle leaks were identified on follow-up computed tomography. This case indicates that radiotherapy can be used to ameliorate lung cancer-related chylothorax and chylopericardium. </p>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 61 (13), 2039-2043, 2022-07-01
一般社団法人 日本内科学会